期刊文献+

保留不同胃容量的Rou-en—Y胃旁路术对糖尿病大鼠降糖效果的比较 被引量:2

Comparative effects of Roux-en-Y gastric bypass procedures preserving different gastric volume on blood glucose in Goto-Kakizaki rats
原文传递
导出
摘要 目的观察保留不同胃容量的Roux-en-Y胃旁路术(RYGBP)对糖尿病大鼠降糖效果的比较。方法36只雄性Got0,Kakizaki(GK)大鼠随机分3组,分别为全胃切除RYGBP、胃大部切除RYGBP和保留全胃RYGBP组,每组12只。检测术前及术后1、3、6、12和24周各组大鼠体质量、日均摄食量和空腹血糖水平,测定术前、术后12和24周各组糖化血红蛋白水平及口服葡萄糖后0、30、60、120和180min血糖值,描制血糖值随时间变化曲线,计算糖耐量曲线下面积(AUC)。结果与术前比较.术后1周各组摄食量和体质量显著减少(P〈O.01),术后3周胃大部切除RYGBP组和保留全胃RYGBP组大鼠摄食量及体质量较术后1周明显增加(氏0.01),而全胃切除RYGBP组大鼠摄食量及体质量较其余两组低(P〈O.05)。术后24周。3组大鼠空腹血糖分别为(7.3±1.5)、(7.5±2.0)和(8.3±1_3)mmol/L,均低于术前水平[(13.2±1.6)、(13.6±2.5)和(12.9±2.0)mmol/L,P〈0.01]。而3组间比较,差异无统计学意义(P〉O.05);糖化血红蛋白则分别为(6-3±1.3)%、(6.4±.2.0)%和(7.0±1.3)%,均低于术前[(10.2±.2.6)%、(9.6±2.5)%和(9.9±2.0)%,P〈0.01],而3组间比较,差异无统计学意义(P〉O.05):3组术后糖耐量试验和AUC变化趋势与之类似。结论RYGBP可有效控制血糖水平.其降糖效果与胃容积的大小无明显联系。 Objective To compare the effects of Roux-en-Y gastric bypass (RYGBP) procedures preserving different gastric volume on blood glucose of rats with non-obese type 2 diabetes. Methods A total of 36 Goto-Kakizaki rats randomly underwent one of the following procedures: gastric bypass with different types of anastorrlosis including the Roux-en-Y of total stomach excision (n=12), the Roux-en-Y of partial stomach excision (n=12) and the Roux-en-Y of stomach preservation (n=12). Rats were observed for 24 weeks after surgery. Body weight, food intake and fasting blood glucose level were tested at 0 (preoperative), 1, 3, 6, 12, 24 weeks. Hematoglobin Alc (HbAle) level was measured at 0, 12, 24 weeks and glucose tolerance test (OGTr) was performed in conscious rats before (baseline) and then 30, 60, 120, and 180 minutes. Change of blood glucose over time was depicted. Area under curve (AUC) of glucose tolerance were calculated. Results Compared with preoperative levels, the weight and food intake of all the rats were significantly decreased at 1 week after surgery (P〈0.01). At 3 weeks after operation, the weight and food intake were significantly increased compared with 1 week after operation in the Roux-en-Y of partial stomach excision and the Roux-en-Y of stomach retention (P〈0.01). In the Roux-en-Y of total stomach excision, the weight andfood intake were significantly lower compared with other two groups (P〈0.05). At 24 weeks after operation, the levels of fasting blood glucose were (7.3+1.5), (7.5±2.0) and (8.3±1.3) mmol/L, which were lower than the preoperative levels [(13.2±1.6), (13.6±2.5) and (12.9±2.0) mmol/L, P〈0.01 ] in the three groups. There were no significant differences among the three groups (P〉0.05). At 24 weeks after operation, the HbAlc levels were (6.3±1.3)%, (6.4±2.0)% and (7.0±1.3)%, which were lower than the preoperative level[ (10.2±2.6)%, (9.6±2.5) and (9.9±2.0)%, P〈0.01 ]. There were no significant differences among the three groups(P〉0.05). The trend of the glucose tolerance test and AUC were similar in the three groups after operation. Conclusion Roux-en-Y gastric bypass in non- obese diabetic rats is effective in terms of glucose control and the efficacy of gastric bypass has no obvious association with the stomach volume.
出处 《中华胃肠外科杂志》 CAS 2012年第1期39-42,共4页 Chinese Journal of Gastrointestinal Surgery
基金 福建省重点科技计划项目(2009Y0039) 南京军区医药卫生科研重点专项(092031)
关键词 2型糖尿病 Goto-Kakizaki大鼠 Roux-en—Y胃旁路术 血糖 Type 2 diabetes mellitus Goto-Kakizaki rat Roxu-en-Y gastric bypass Blood glucose
  • 相关文献

参考文献9

  • 1Cummings DE, Flum DR. Gastrointestinal surgery as treatment for diabetes. JAMA, 2008,299 ( 3 ) : 341-343.
  • 2王瑜,王燕婷,王烈.胃转流术对非肥胖型2型糖尿病的治疗作用[J].中国普通外科杂志,2008,17(10):1003-1006. 被引量:62
  • 3郑成竹,张鼎宇.2型糖尿病的外科治疗[J].中华胃肠外科杂志,2009,12(6):545-548. 被引量:20
  • 4Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004,239( 1 ) : 1-11.
  • 5王瑜,张再重,王烈,邓治洲,焦亚彬,邹忠东.不同肠段小肠旷置术对2型糖尿病大鼠血糖控制的作用[J].中华医学杂志,2009,89(40):2858-2861. 被引量:3
  • 6Pories WJ, Albrecht RJ. Etiology of type 1I diabetes mellitus: role of the foregut . World J Surg, 2001,25(4) :527-531.
  • 7Patriti A, Aisa MS, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery, 2007,142( 1 ) :74-85.
  • 8Scopinaro N. Biliopancreatic diversion:mechanisms of action and long-term results. Obes Surg, 2006,16(6):683-689.
  • 9张新国,杨学军.手术治疗2型糖尿病的突破性进展[J].武警医学,2004,15(12):883-884. 被引量:61

二级参考文献69

  • 1韩冰,张宏光,周晨光,吉国辉.老年糖尿病性下肢动脉硬化闭塞症的外科治疗[J].中国普通外科杂志,2007,16(6):536-538. 被引量:13
  • 2Detoumay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab, 2000,26 (5) : 363-369.
  • 3Nelms M, Sucher K, Long S. Nutrition Therapy and Pathophysiology. Belmont: Thomson Higher Education.2007.
  • 4Mason EE. Development and future of gastroplasties for morbid obesity. Arch Surg, 2003,138(4) :361-366.
  • 5Jamieson AC. Why the operation I prefer is the modified long vertical gastroplasty. Obes Surg, 1993,3(3) : 297-301.
  • 6Dixon AF, Dixon JB, O'Brien PE. Laparoseopic adjustable gastric banding induces prolonged satiety:a randomized blind crossover study. J Clin Endoerinol Metab, 2005,90(2) : 813-919.
  • 7Busetto L, Segato G, De Marchi F, et al. Postoperative management of laparoscopic gastric banding. Obes Surg, 2003, 13( 1 ) : 121-127.
  • 8American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. Asmbs position statement on sleeve gastrectomy as a bariatric procedure. 2007. Http://www. pugetsoundsurgicalcenter.com/sleeve_statement .pdf.
  • 9Bernante P, Foletto M, Busetto L, et al. Feasibility of laparoscopic sleeve gastrectomy as a revision procedure for prior laparoscopic gastric banding. Obes Surg, 2006,16 (10) : 1327- 1330.
  • 10Totte E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastrie device:experience with the bioenterics intragastric balloon. Obes Surg, 2001,11 (4) : 519-523.

共引文献138

同被引文献30

  • 1Inzucchi SE. Clinical practice. Diagnosis of diabetes [J]. N Engl J Med, 2012, 367(6): 542-550.
  • 2Yang W, Lu J, Wang J0 et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.
  • 3Rubino F, Kaplan LM, Schauer PR, et al. The diabetes surgery summit consensus conference: recommendations for the evalu- ation and use of gastrointestinal surgery to treat type 2 diabetes mellitus [J]. Ann Surg, 2010, 251(3): 399-405.
  • 4Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes [ J ]. Lancet, 2012,379(9833): 2300-2311.
  • 5Henry B, Yoav A, Eugene B, et al. Bariatric surgery: a syste-matic review and meta-analysis [J]. JAMA, 2004, 292(14): 1724-1737.
  • 6Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery [J]. N Engl J Meal, 2004, 351(26): 2683-2693.
  • 7American Diabetes Association. Standards of medical care in diabetes--2012 [J]. Diabetes Care, 2012, 35 Suppl 1 : S11-D63.
  • 8Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gas- trectomy versus medical treatment [ J ]. Surg Obes Relat Dis, 2012, 8(1): 20-24.
  • 9Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanism of diabetes remission after gastrointestinal surgery [J]. Endocrinology, 2009, 150(6): 2518-2525.
  • 10Lee WJ, Chen CY, Chong K, et al. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy [J]. Surg Obes Relat Dis, 2011, 7(6): 683 -690.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部